SCHEMBL24517792

SCHEMBL24517792

O=C(O)C1CC(c2cccc(OCc3ccccn3)c2)=NO1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.62
▸ CYP2C19 P33261 5/20 0.62
▸ ALDH1A1 P00352 5/20 0.52
▸ LMNA P02545 4/20 0.51
▸ CYP1A2 P05177 4/20 0.51
▸ TSHR P16473 3/20 0.51
▸ CYP2D6 P10635 2/20 0.51
▸ NPC1 O15118 2/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ MAPK10 P53779 4/20 0.47
▸ HPGD P15428 1/20 0.47
▸ CA1 P00915 1/20 0.47
▸ CA2 P00918 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ RAB9A P51151 1/20 0.45
▸ GPR132 Q9UNW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29845959 0.92 CYP3A4 (0.62) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL29846946 0.87 CYP3A4 (0.60) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL24518327 0.87 CYP3A4 (0.60) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL24518330 0.85 CYP3A4 (0.67) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL29846835 0.83 CYP3A4 (0.60) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL24518117 0.83 CYP3A4 (0.54) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL25400841 0.81 CYP3A4 (0.58) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL25400834 0.81 CYP3A4 (0.58) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL10389741 0.81 TSHR (0.59) CYP3A4CYP2C19ALDH1A1LMNACYP1A2
SCHEMBL25400116 0.78 POLB (0.51) CYP3A4CYP2C19ALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570675-B2 Boronic acid compounds LG CHEM, LTD. (KR) 2026-03-10 — — US disclosed
US-20240101579-A1 BORONIC ACID COMPOUNDS LG CHEM, LTD. (KR) 2024-03-28 — — US disclosed
EP-4242213-A1 BORONIC ACID COMPOUND Lg Chem, Ltd. (KR) 2023-09-13 — — EP disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 — — WO disclosed
WO-2022123530-A1 BORONIC ACID COMPOUND 주식회사 엘지화학 2022-06-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570675-B2 Boronic acid compounds PSMB6, PSMB3, PSMB2 CYP3A4 1946/4885CYP2C19 2008/4885ALDH1A1 3621/4885
US-20240101579-A1 BORONIC ACID COMPOUNDS PSMB11, PSMB1, BACH1 CYP3A4 3383/4885CYP2C19 2880/4885ALDH1A1 2005/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback